CARsgen Therapeutics Holdings Ltd
HKEX:2171
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Price:
6.19 HKD
-0.8%
Market Closed
Updated:
May 5, 2024
Income Statement
Earnings Waterfall
CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings Ltd
|
Revenue
|
0
CNY
|
|
Operating Expenses
|
-767.6m
CNY
|
|
Operating Income
|
-767.6m
CNY
|
|
Other Expenses
|
19.9m
CNY
|
|
Net Income
|
-747.8m
CNY
|
Income Statement
CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings Ltd
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
26
N/A
|
26
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
26
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(613)
|
(752)
|
(806)
|
(804)
|
(768)
|
|
| Selling, General & Administrative |
(124)
|
(119)
|
(130)
|
(131)
|
(132)
|
|
| Research & Development |
(468)
|
(603)
|
(627)
|
(620)
|
(662)
|
|
| Depreciation & Amortization |
(36)
|
(45)
|
(59)
|
(71)
|
0
|
|
| Other Operating Expenses |
14
|
16
|
10
|
18
|
26
|
|
| Operating Income |
(587)
N/A
|
(726)
-24%
|
(806)
-11%
|
(804)
+0%
|
(768)
+5%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
6
|
6
|
(85)
|
(115)
|
20
|
|
| Total Other Income |
(4 156)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4 737)
N/A
|
(719)
+85%
|
(891)
-24%
|
(919)
-3%
|
(747)
+19%
|
|
| Net Income | ||||||
| Tax Provision |
(8)
|
(8)
|
(1)
|
(1)
|
(0)
|
|
| Income from Continuing Operations |
(4 744)
|
(727)
|
(892)
|
(920)
|
(748)
|
|
| Net Income (Common) |
(4 744)
N/A
|
(727)
+85%
|
(892)
-23%
|
(920)
-3%
|
(748)
+19%
|
|
| EPS (Diluted) |
-12.26
N/A
|
-1.32
+89%
|
-1.62
-23%
|
-1.66
-2%
|
-1.34
+19%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
